NICOLAS BARTHELEMY
CIK 1283576 · VP, Corporate Development · last filed 2026-05-18
NICOLAS BARTHELEMY is a VP, Corporate Development who has filed 97 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for RGEN, was dated May 18, 2026. Across all open-market trades the lifetime net is −$15.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $3.0M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$3.05M
6
97
-$15.44M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RGEN | Director | 5,436 | $130.59 | $709.9K | -$2.99M | 20 | 2026-05-18 |
| TWST | Director | 23,021 | $76.17 | $1.75M | -$637.9K | 9 | 2022-11-23 |
| MASS | VP, Corporate Development | 28,920 | $8.27 | $239.2K | -$236.4K | 5 | 2022-06-17 |
| STANDARD BIOTOOLS INC. (FLDM) Delisted | Director | 204,077 | $3.71 | $757.1K | $225.1K | 21 | 2022-04-04 |
| LIFE | Pres, Commercial Operations | 22,210 | $15.61 | $346.7K | -$5.59M | 23 | 2011-05-02 |
| Life Technologies Corp (IVGN) Delisted | SVP, Cell Culture Systems | 33,540 | — | — | -$6.22M | 19 | 2008-11-18 |
Recent Filings
97 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-18 | RGEN | Grant (A) | +995 | $0 | EDGAR |
| 2025-05-21 | RGEN | Grant (A) | +973 | $0 | EDGAR |
| 2024-06-14 | RGEN | Buy (P) | +1,200 | $150.5K | EDGAR |
| 2024-05-20 | RGEN | Grant (A) | +701 | $0 | EDGAR |
| 2023-05-22 | RGEN | Grant (A) | +686 | $0 | EDGAR |
| 2022-11-23 | TWST | Exer (M) | +9,082 | $211.9K | EDGAR |
| 2022-06-17 | MASS | Exer (M) | +1,379 | $0 | EDGAR |
| 2022-05-31 | RGEN | Grant (A) | +534 | $0 | EDGAR |
| 2022-05-13 | TWST | Buy (P) | +8,550 | $250.1K | EDGAR |
| 2022-04-04 | STANDARD BIOTOOLS INC. (FLDM) Delisted | Exer (M) | +20,993 | $78.5K | EDGAR |